Glutaminolysis and autophagy in cancer - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Autophagy Year : 2015

Glutaminolysis and autophagy in cancer


The remarkable metabolic differences between cancer cells and normal cells result in the potential for targeted cancer therapy. The upregulation of glutaminolysis provides energetic advantages to cancer cells. The recently described link between glutaminolysis and autophagy, mediated by MTORC1, may constitute an attractive target for therapeutic strategies. A combination of therapies targeting simultane-ously cell signaling, cancer metabolism, and autophagy can solve therapy resistance and tumor relapse problems, commonly observed in patients treated with most of the current targeted therapies. In this review we summarize the mechanistic link between glutaminolysis and autophagy, and discuss the impacts of these processes on cancer progression and the potential for therapeutic intervention.
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-03653052 , version 1 (27-04-2022)



Victor Villar, Faten Merhi, Mojgan Djavaheri-Mergny, Raúl Durán. Glutaminolysis and autophagy in cancer. Autophagy, 2015, 11 (8), pp.1198-1208. ⟨10.1080/15548627.2015.1053680⟩. ⟨inserm-03653052⟩


8 View
1 Download



Gmail Facebook Twitter LinkedIn More